Editorials: Cell Cycle Features
Target of rapamcyin (TOR)-based therapeutics for cardiomyopathy: Insights from zebrafish genetics
Purchase or Subscribe
Volume 11, Issue 3 February 1, 2012
Pages 428 - 429
http://dx.doi.org/10.4161/cc.11.3.19164
Authors: Yonghe Ding, Xiaojing Sun, Margaret Redfield, Sudhir Kushwaha and Xiaolei Xu
View affiliations Hide affiliations
- Yonghe Ding
-
Department of Biochemistry and Molecular Biology; Mayo Clinic College of Medicine; Rochester, MN USA
- Xiaojing Sun
-
Department of Biochemistry and Molecular Biology; Mayo Clinic College of Medicine; Rochester, MN USA
- Margaret Redfield
-
Division of Cardiovascular Diseases; Department of Medicine; Mayo Clinic College of Medicine; Rochester, MN USA
- Sudhir Kushwaha
-
Division of Cardiovascular Diseases; Department of Medicine; Mayo Clinic College of Medicine; Rochester, MN USA
- Xiaolei Xu
-
Corresponding author: xu.xiaolei@mayo.edu
Department of Biochemistry and Molecular Biology; Mayo Clinic College of Medicine; Rochester, MN USA
Preview
Abstract:
Comment on: Ding Y, et al. Circ Res 2011; 109:658-69.
